MORPHEUS: A Phase Ib/II Multi-Trial Platform Evaluating the Safety and Efficacy of Cancer Immunotherapy (Cit)-Based Combinations in Patients (pts) with Non-Small Cell Lung Cancer (NSCLC)
Journal of clinical oncology（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要